The net result, demonstrated in numerous animal studies and supported by early human trials, is an attenuation of obesity-related phenotypes: less weight gain, lower adiposity, improved insulin sensitivity, and a more anti-inflammatory status. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.